Teva has announced a shortage of Zanosar (streptozocin injection) due to manufacturing delays.

Zanosar is an anthracycline indicated for the treatment of metastatic islet cell carcinoma of the pancreas.

For more information call (888) TevaUSA or visit www.fda.gov/cder/drug/shortages/default.htm#Zanosar.